Stay updated on CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page.

Latest updates to the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. There are no user-facing changes; to avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision history shows an update from v3.4.0 to v3.4.1; no substantive content changes are evident on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded UI elements and labels: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check33 days agoChange DetectedA new revision entry 'Revision: v3.3.4' has been added, replacing the previous 'Revision: v3.3.3'. This is a metadata update that does not alter the study information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded a dedicated Locations section listing study sites in Florida, Massachusetts, Michigan, New York, and Ohio; removed the HHS Vulnerability Disclosure and the individual location blocks.SummaryDifference0.5%

- Check83 days agoChange DetectedAdded a PubMed auto-fill note for publications and updated the revision tag to v3.3.2, replacing the previous PubMed-origin wording and the v3.2.0 tag.SummaryDifference0.1%

Stay in the know with updates to CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page.